A3P Biomedical AB

A Swedish diagnostics company

Unternehmenstyp

KMU


Branche

Medizin / Pharma / Gesundheit / Pflege


Standort

Headquarters in Stockholm and laboratory in Uppsala.

A3P Biomedical AB entdecken

A3P Biomedical is a Swedish diagnostics company that specializes in advanced prostate cancer diagnostics. A3P’s main product, Stockholm3, is a clinically and commercially validated blood test for early detection of aggressive prostate cancer.

Our vision

To radically reduce mortality in prostate cancer - one of the most prevalent cancers globally

Our mission

To provide earlier and more precise risk assessment enabling improved diagnostic pathways and treatment that significantly improve the quality of life for men while reducing the societal burden of prostate cancer

Core values

  • Understand our customers’ needs and deliver innovative solutions
  • Operate with integrity, accountability and sense of urgency
  • Build trust through collaboration, transparency and communication
  • Treat people with respect and embrace diversity

Background

A3P Biomedical AB (publ) was established in 2020, but its operations began back in 2018 when we started conducting analyses of Stockholm3. The development of a multiparametric test began in 2011 at Karolinska Institutet. Read more about A3P Biomedical’s history here.

Laboratory

The company has a wholly owned subsidiary laboratory for analyzing Stockholm3. The laboratory works in accordance with the Patient Safety Act 2010: 659 and is registered as a care provider with the Swedish Health and Care Inspectorate (IVO).

Stockholm3

Stockholm3 has been developed by researchers at Karolinska Institutet. Studies have shown that compared with the current standard PSA test (prostate-specific antigen), Stockholm3 yields more accurate and clearer test results for early detection of prostate cancer. Stockholm3 finds 100 percent more aggressive prostate cancers and reduce unnecessary biopsies by 50 percent compared to current practice. Stockholm3 has been tested on more than 75,000 men and provides clear result and recommendations.

Why A3P Biomedical?

At A3P Biomedical you will have the opportunity to work for an attractive company with global ambitions. Your work will help improve men’s health and quality of life as well as radically improve prostate cancer diagnosis. If you want to learn more about who we are and what we do, please visit our website at: A3P Biomedical –

Wie ist es, hier zu arbeiten?

Das Wichtigste auf einen Blick

  • Gründungsjahr

    2020

  • Geschlechterverteilung

    61%

    39%

  • Internationale Präsenz

    3 Länder